Ando S, Kojima N, Moyama C, Fujita M, Ohta K, Ii H, et al. JCI‑20679 suppresses the proliferation of glioblastoma stem cells by activating AMPK and decreasing NFATc2 expression levels. Mol Med Rep. 2022;26: pubmed publisher

Tuzmen C, Cairns T, Atanasiu D, Lou H, Saw W, Hall B, et al. Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies. Mol Ther Methods Clin Dev. 2020;16:145-154 pubmed publisher

Suzuki S, Yamamoto M, Sanomachi T, Togashi K, Sugai A, Seino S, et al. Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction. Cancers (Basel). 2019;11: pubmed publisher

Wiesner S, Decker S, Larson J, Ericson K, Forster C, Gallardo J, et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 2009;69:431-9 pubmed publisher